Search research articles
Contact Us
Filters
Showing results (171-180 of 265) with videos related to
Page
of 27
Sort By:
Annals of Surgical Oncology
|
November 12, 2025
Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous Neoplasms
Ashlee N Seldomridge, Michael G White, Christopher Scally, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinoma
Saikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.
Clinical Colorectal Cancer
|
February 4, 2020
Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer
Shailesh M Advani, Quilling Shi, Michael J Overman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 21, 2021
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer
Giovanni Randon, Rossana Intini, Chiara Cremolini, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2023
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
Vincenzo Nasca, Francesco Barretta, Francesca Corti, et al.
Molecular Cancer Therapeutics
|
October 5, 2013
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations
Prasanth Ganesan, Filip Janku, Aung Naing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
T Yoshino, G Pentheroudakis, S Mishima, et al.
Annals of Surgical Oncology
|
October 23, 2023
Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit
Neal Bhutiani, Travis E Grotz, Seth J Concors, et al.
Oncotarget
|
August 20, 2016
Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
Michael J Overman, Van Morris, Helen Moinova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary
Kanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
Page
of 27
Search research articles
Search
Showing results (171-180 of 265) with videos related to
Sort By:
Page
of 27
Annals of Surgical Oncology
|
November 12, 2025
Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous Neoplasms
Ashlee N Seldomridge, Michael G White, Christopher Scally, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinoma
Saikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.
Clinical Colorectal Cancer
|
February 4, 2020
Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer
Shailesh M Advani, Quilling Shi, Michael J Overman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 21, 2021
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer
Giovanni Randon, Rossana Intini, Chiara Cremolini, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2023
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
Vincenzo Nasca, Francesco Barretta, Francesca Corti, et al.
Molecular Cancer Therapeutics
|
October 5, 2013
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations
Prasanth Ganesan, Filip Janku, Aung Naing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
T Yoshino, G Pentheroudakis, S Mishima, et al.
Annals of Surgical Oncology
|
October 23, 2023
Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit
Neal Bhutiani, Travis E Grotz, Seth J Concors, et al.
Oncotarget
|
August 20, 2016
Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
Michael J Overman, Van Morris, Helen Moinova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary
Kanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
Page
of 27